Peer-reviewed veterinary case report
Adverse drug reaction profile of third-generation smallpox vaccines used in France during the 2022 monkeypox epidemic.
- Journal:
- AIDS (London, England)
- Year:
- 2024
- Authors:
- Fresse, Audrey et al.
- Affiliation:
- Laboratoire de Pharmacologie-Toxicologie
Abstract
Due to the start of the monkeypox epidemic in 2022, we retrospectively analyzed the adverse drug reactions (ADRs) reported in France after monkeypox vaccinations with the third-generation smallpox vaccine. Ninety-eight cases, representing 172 ADRs, were reported. ADRs were mostly expected reactogenicity reactions occurring within days after the first dose of vaccine and having a quick favorable outcome. Unexpected facial palsy and vaccination failure are discussed.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/38482909/